Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 9

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 4
Chunk 9
---
10       6,260,000        $626,000  
  31-Dec-2021                        Private Placement @                                                  $0.10       8,740,000        $874,000  
  31-Dec-2021                        Private Placement @                                                  $0.22       7,000,000      $1,540,000  

   9  

4. B.
Business Overview

Operations
& Principal Activities

Avricore
Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward.
Through its flagship offering HealthTab™ (a wholly owned subsidiary), it provides a turnkey point-of-care testing platform, creating
value for stakeholders and better outcomes for patients.

During
the year ended December 31, 2019, the Company discontinued its over-the-counter (OTC) pharmaceutical products business and ceased production
and sales of all generic and over-the-counter pharmaceuticals.

Avricore
sees the community pharmacy as underutilized and is committed to supporting their ability to deliver innovation to modern healthcare
consumers. Pharmacies face reduced revenues as a result of disruptions to the sector and regulatory changes. As a result, pharmacy owners
are actively looking for innovations in service and value-added services, like HealthTab™, to support their business growth beyond
the traditional dispensing model. Community pharmacy is expected to focus increasingly on cognitive services with attendant point of
care testing in the future.

The
Company hopes to improve health outcomes for patients and lower overall healthcare system costs in this way, bridging traditional healthcare
platforms with disruptive innovations and eventually achieving the healthcare cost savings government and private payors are seeking
to achieve.

This
is all possible thanks to the Company’s HealthTab™ technology, which provides lab-accurate results for specific blood work
within 12 minutes. Installed at the pharmacy and administered by the attending pharmacist, the patient can quickly access up to 27 bio-markers.
The advantage of this innovation is that a consumer can quickly access data on their health with a simple patient assisted finger prick
to share with their physician and healthcare team, track their health overtime, measure the impacts of therapies they are undertaking
and screen for potential health risks.

HealthTab™
allows for these innovations to be accessed in a low barrier manner at the community pharmacy level for a balanced cost. The pharmacist
is also able to benefit from this new revenue stream, build a deeper relationship with clientele and fully realize their ability to deliver